Metabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway
CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)
DOI: 10.1002/cns.71194 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 07.10.2026. Verfasst von Mengya Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ningxia Medical University, Yinchuan, Ningxia, China. Hauptthemen laut MEDLINE: Ferroptosis, Glutathione, Cognitive Dysfunction, Aging. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan of Gansu Province, Science and Technology Program of Gansu Province.
Abstract (Originalsprache)
Objective
This study aimed to examine the potential neuroprotective effects of SXZ on cognitive impairment in naturally aging rats and to explore the underlying molecular mechanisms.
Methods
Eighteen‐month‐old Sprague–Dawley rats were used as a natural aging model and administered Shenxian Zhou (SXZ) for 6 months. Cognitive function was assessed using behavioral evaluations. Hematoxylin–eosin, Nissl, and immunofluorescence staining for NeuN were performed to evaluate neuronal pathology in aging rats. Metabolomics analysis was performed to characterize hippocampal metabolites, followed by molecular validation.
Results
SXZ attenuated age‐related cognitive decline and reduced hippocampal pathological and neuronal damage in naturally aging rats. SXZ‐H significantly modulated glutathione metabolism and ferroptosis‐associated signaling pathways. Transmission electron microscopy revealed mitochondrial morphological changes consistent with ferroptosis in hippocampal neurons of naturally aging rats. Molecular biology experiments further indicated that, subsequent to SXZ‐H intervention, lipid peroxidation and oxidative stress levels were significantly reduced. Furthermore, expression levels of p53 and Keap1 genes and proteins were significantly downregulated, whereas the expression of SLC7A11, GPX4, Nrf2, and HO‐1 genes and proteins was notably upregulated.
Conclusion
SXZ‐H effectively mitigates cognitive impairment in naturally aging rats, an effect that may be mediated by promoting glutathione metabolism and regulating key ferroptosis‐related proteins, thereby inhibiting neuronal ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningxia Medical University, Yinchuan, Ningxia, China.
- Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
ORCID-Profile: Min Bai
Förderung
- Science and Technology Plan of Gansu Province
- Science and Technology Program of Gansu Province
Zitieren
APA
Liu, M., Li, S., Liang, Y., Zhang, Y., Jia, X., Duan, Y., & Bai, M. (2026). Metabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71194
Vancouver
Liu M, Li S, Liang Y, Zhang Y, Jia X, Duan Y, et al. Metabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71194
BibTeX
@article{Liu2026,
author = {Liu, Mengya and Li, Shunyi and Liang, Yonglin and Zhang, Yugui and Jia, Xutong and Duan, Yongqiang and Bai, Min},
title = {Metabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {10},
doi = {10.1002/cns.71194}
}
EUVIMED